Highbridge Capital Management’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Highbridge Capital Management’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-922,075	Closed	-$9.48M	–	564
2022 Q4	$9.48M	Sell	922,075 -39,600	-4%	-$402K	0.26%	139
2022 Q3	$9.68M	Buy	961,675 +4,750	+0.5%	+$47.7K	0.14%	201
2022 Q2	$9.59M	Buy	956,925 +59,514	+7%	+$595K	0.22%	175
2022 Q1	$8.97M	Sell	897,411 -226,413	-20%	-$2.25M	0.21%	160
2021 Q4	$11.1M	Buy	+1,123,824	New	+$11.1M	0.24%	145

Other funds holding IQMD

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Highbridge Capital Management's IQMD Position: Q1 2023 in Review

Highbridge Capital Management sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 922,075 shares — an estimated $9.48M sold.

Highbridge Capital Management first reported a position in IQMD in Q4 2021 and held it in 5 quarters. The position peaked at $11.1M in Q4 2021. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

Highbridge Capital Management reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Highbridge Capital Management sold 922,075 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $9.48M.
Highbridge Capital Management first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 5 quarters.
Highbridge Capital Management's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $11.1M in Q4 2021.
8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Highbridge Capital Management's 13F filing for Q1 2023, filed 11 May 2023.